簡介:他扎羅汀,Tazarotene是選擇性視黃酸受體 (RAR) 激動劑,用于治療斑塊狀銀屑病和尋常痤瘡。
他扎羅汀物理化學(xué)性質(zhì):
密度 |
1.2±0.1 g/cm3 |
沸點 |
499.8±45.0 °C at 760 mmHg |
熔點 |
97-98oC |
分子式 |
C21H21NO2S |
分子量 |
351.462 |
閃點 |
256.1±28.7 °C |
精確質(zhì)量 |
351.129303 |
PSA |
64.49 |
LogP |
6.22 |
外觀性狀 |
白色固體 |
蒸汽壓 |
0.0±1.3 mmHg at 25°C |
折射率 |
1.625 |
儲存條件 |
Store at +4°C |
他扎羅汀詳細介紹:
中文名稱: |
他扎羅汀 |
中文別名: |
他扎羅汀;6-[2-(4,4-二甲基二氫苯并噻喃-6-基)乙炔基]吡啶-3-甲酸乙酯;Tazarotene 他扎羅汀;他扎羅汀標準品;他扎羅汀雜質(zhì) |
英文名稱: |
Tazarotene |
英文別名: |
Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate;TAZAROTENE;agn190168;6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]- 3-pyridinecarboxylic Acid Ethyl Ester;Tazorac;Zorac;6-[(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran)-6-yl]nicotinic acid ethyl ester;ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate;6-[(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid ethyl ester;AGN-190168;ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl] nicotinate;Ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate;Avage;Tazarotene(Avage);Fabior;Tazarotene [USAN:INN];AGN 190168;Tazarotene (Avage);Zora;C21H21NO2S;81BDR9Y8PS;OGQICQVSFDPSEI-UHFFFAOYSA-N;3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester;ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)et |
CAS號: |
118292-40-3 |
分子式: |
C21NO2SH21 |
分子量: |
351.46 |
詳細描述: |
博飛美科提供118292-40-3,他扎羅汀,Tazarotene,Perfemiker,上?,F(xiàn)貨。 Perfemiker,致力于提供高品質(zhì)、高性價比小分子化合物的產(chǎn)品。 Perfemiker小分子化合物大量庫存,提供超過2萬種的抑制劑、激動劑、拮抗劑等產(chǎn)品,是藥物及疾病研究的重要原料供應(yīng)商。 外用視黃酸、抗增殖、TIG3腫瘤抑制劑的誘導(dǎo)物,Tazarotene是選擇性視黃酸受體 (RAR) 激動劑,用于治療斑塊狀銀屑病和尋常痤瘡。 查詢關(guān)鍵詞:“118292-40-3,他扎羅汀,Tazarotene,Perfemiker,上海現(xiàn)貨”。 |
他扎羅汀參考文獻:
[1]. Talpur R, et al. Efficacy and safety of topical tazarotene: a review. Expert Opin Drug Metab Toxicol. 2009 Feb;5(2):195-210.
[2]. Nagpal S, et al. Negative regulation of two hyperproliferative keratinocyte differentiation markers by a retinoic acidreceptor-specific retinoid: insight into the mechanism of retinoid action in psoriasis. Cell Growth Differ. 1996 Dec;7(12):1783-91.
[3]. Tang-Liu DD, et al. Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis. Clin Pharmacokinet. 1999 Oct;37(4):273-87.